Large gap with delayed quotes
Analysis date: 13.10.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 22.05.2026.
Quality
Weak
Weak
Two stars since 15.09.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 11.09.2026 at a price of 587.52.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 05.06.2026.
4wk Rel Perf
1.87%
1.87%
The four-week dividend-adjusted overperformance versus SP500 is 1.87%.
Risk
High
High
The stock has been on the high-sensitivity level since 23.01.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.61%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.32%.
Mkt Cap in $bn
17.31
17.31
With a market capitalization >$8bn, MEDPACE HOLDINGS is considered a large-cap stock.
G/PE Ratio
0.77
0.77
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
28.19
28.19
The estimated PE is for the year 2028.
LT Growth
21.55%
21.55%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
11
11
Over the last seven weeks, an average of 11 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
5
5
For 1% of index variation, the stock varies on average by 0.05%.
Correlation
0.01
0.01
Stock movements are totally independent of index variations.
Value at Risk
226.83
226.83
The value at risk is estimated at USD 226.83. The risk is therefore 37.19%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.11.2020
27.11.2020